Healthpeak Properties, Inc. (NYSE:DOC) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Healthpeak Properties, Inc. (NYSE:DOC) have received a consensus rating of “Moderate Buy” from the twelve analysts that are covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $20.1818.

DOC has been the topic of several recent research reports. Jefferies Financial Group lowered Healthpeak Properties from a “buy” rating to a “hold” rating and decreased their price target for the company from $21.00 to $17.00 in a report on Monday, December 15th. Raymond James Financial raised shares of Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 target price on the stock in a research note on Monday, September 15th. Wells Fargo & Company raised their target price on shares of Healthpeak Properties from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 25th. Evercore ISI cut their price target on shares of Healthpeak Properties from $22.00 to $21.00 and set an “outperform” rating on the stock in a report on Monday, December 15th. Finally, Cantor Fitzgerald started coverage on shares of Healthpeak Properties in a research report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price objective on the stock.

Institutional Trading of Healthpeak Properties

Several hedge funds and other institutional investors have recently made changes to their positions in DOC. State Street Corp boosted its holdings in Healthpeak Properties by 1.8% in the third quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock worth $947,889,000 after acquiring an additional 895,460 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Healthpeak Properties by 41.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock worth $540,730,000 after purchasing an additional 8,212,504 shares in the last quarter. Geode Capital Management LLC boosted its stake in Healthpeak Properties by 1.0% in the 2nd quarter. Geode Capital Management LLC now owns 19,071,094 shares of the real estate investment trust’s stock worth $332,625,000 after purchasing an additional 197,540 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in Healthpeak Properties by 2.8% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 10,520,156 shares of the real estate investment trust’s stock worth $184,208,000 after purchasing an additional 282,155 shares during the last quarter. Finally, Cullen Capital Management LLC increased its stake in Healthpeak Properties by 6.7% during the 3rd quarter. Cullen Capital Management LLC now owns 10,232,875 shares of the real estate investment trust’s stock valued at $195,960,000 after purchasing an additional 641,771 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Trading Up 0.5%

Shares of DOC stock opened at $16.11 on Monday. Healthpeak Properties has a 1 year low of $15.71 and a 1 year high of $21.28. The firm has a fifty day moving average price of $17.42 and a 200-day moving average price of $17.77. The company has a market cap of $11.19 billion, a price-to-earnings ratio of -322.04, a PEG ratio of 4.08 and a beta of 1.11. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.22 and a quick ratio of 1.22.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Thursday, October 23rd. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.01. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. The firm had revenue of $705.87 million during the quarter, compared to analysts’ expectations of $681.65 million. During the same period in the prior year, the company posted $0.45 earnings per share. The company’s revenue for the quarter was up .8% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, equities analysts predict that Healthpeak Properties will post 1.86 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 19th will be issued a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 7.6%. The ex-dividend date is Friday, December 19th. Healthpeak Properties’s dividend payout ratio is presently -2,440.00%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.